Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC

Published:2024-08 Issue: Volume: Page:
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Leonetti Alessandro^ORCID,Cervati Veronica,Minari Roberta^ORCID,Scarlattei Maura,Verzè Michela,Peroni Marianna^ORCID,Pluchino Monica,Bonatti Francesco,Perrone Fabiana^ORCID,Mazzaschi Giulia^ORCID,Cosenza Agnese,Gnetti Letizia^ORCID,Bordi Paola^ORCID,Ruffini Livia,Tiseo Marcello^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Airc Italian Foundation for Cancer Research

Publisher

Elsevier BV

Reference29 articles.

1. Comprehensive molecular profiling of lung adenocarcinoma;Nature,2014

2. Screening for epidermal growth factor receptor mutations in lung cancer;Rosell;N Engl J Med,2009

3. Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?;Recondo;Nat Rev Clin Oncol,2018

4. Osimertinib in untreated EGFR -mutated advanced non–small-cell lung cancer;Soria;N Engl J Med,2018

5. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC;Ramalingam;N Engl J Med,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP